CCLDNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
CareCloud, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.80−0.05 (-2.70%)
Close on Oct 19, 2026
- Market cap
- $76.49M
- P/E (TTM)
- 25.7
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2012 to 2025
Operating margin
9.4%+17.3 pts over 5 years
Net margin
9.0%+17.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +8.7% | -4.6% | +2.8% | +18.0% | |
| Operating income | +24.4% | +19.7% | – | – | |
| Net income | +37.5% | +25.7% | – | – | |
| Free cash flow | +25.5% | +8.6% | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -80.1% | -12.2% | 19.8% | |
| Return on assets | -32.0% | -9.1% | 13.6% | |
| Current ratio | 0.53 | 1.54 | 1.05 | |
| Debt to equity | 0.95 | 0.00 | 0.01 | |
| Net debt to EBITDA | -1.15× | -12.78× | -0.10× | |
| Capex to revenue | 1.9% | 2.5% | 4.0% | |
| Diluted shares | 10M | 13M | 38M |
Where the cash went
Fiscal 2021 to 2025, five years combined
CareCloud generated $99.15M from operations and spent $15.05M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$99.15M
Used
$15.05M
Capital expenditure$15.05M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin9.0%
×Asset turnover1.51×
×Equity multiplier1.46×
=Return on equity, FY202519.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 9.0% | 1.51× | 1.46× | 19.8% |
| FY2024 | 7.1% | 1.48× | 1.63× | 17.2% |
| FY2023 | -41.6% | 1.09× | 1.49× | -67.9% |
| FY2022 | 3.9% | 1.00× | 1.39× | 5.4% |
| FY2021 | 2.0% | 1.00× | 1.40× | 2.8% |
| FY2020 | -8.4% | 1.08× | 1.35× | -12.2% |
| FY2019 | -1.4% | 1.24× | 1.27× | -2.1% |
| FY2018 | -4.2% | 1.38× | 1.24× | -7.2% |
| FY2017 | -17.5% | 1.18× | 1.97× | -40.7% |
| FY2016 | -35.9% | 0.89× | 2.50× | -80.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$10.80M
- Cash generatingOperating cash flow above zero$28.56M
- Return on assets improvedROA up on the prior year10.1% → 15.1%
- Earnings backed by cashOperating cash flow above net income$28.56M vs $10.80M
- Less leverageLong-term debt to assets fell0.0% → 0.5%
- Better liquidityCurrent ratio rose1.27 → 1.05
- No dilutionShare count did not rise16M → 38M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose1.42 → 1.68